Information:
Fel:
ID
31416
Beskrivning
Preliminary Study of Piclozotan in Patients With Motor Complications Associated With Parkinson's Disease; ODM derived from: https://clinicaltrials.gov/show/NCT00623363
Länk
https://clinicaltrials.gov/show/NCT00623363
Nyckelord
Versioner (1)
- 2018-08-20 2018-08-20 -
Rättsinnehavare
See clinicaltrials.gov
Uppladdad den
20 augusti 2018
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Parkinson's Disease NCT00623363
Eligibility Parkinson's Disease NCT00623363
- StudyEvent: Eligibility
Similar models
Eligibility Parkinson's Disease NCT00623363
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Parkinson Disease Disease length
Item
idiopathic parkinson's disease for at least 5 years
boolean
C0030567 (UMLS CUI [1,1])
C0872146 (UMLS CUI [1,2])
C0872146 (UMLS CUI [1,2])
Motor fluctuations | Dyskinesia
Item
presence of motor fluctuations and dyskinesia
boolean
C1868976 (UMLS CUI [1])
C0013384 (UMLS CUI [2])
C0013384 (UMLS CUI [2])
Carbidopa / Levodopa Regimen Stable
Item
stable regimen of levodopa/carbidopa for 30 days
boolean
C0353697 (UMLS CUI [1,1])
C0040808 (UMLS CUI [1,2])
C0205360 (UMLS CUI [1,3])
C0040808 (UMLS CUI [1,2])
C0205360 (UMLS CUI [1,3])
Response Percentage UPDRS | Status post Antiparkinson Agents Dosage Regular
Item
at least 25% response/improvement in updrs part iii scores after dosing with regular pd medications
boolean
C1704632 (UMLS CUI [1,1])
C0439165 (UMLS CUI [1,2])
C3639721 (UMLS CUI [1,3])
C0231290 (UMLS CUI [2,1])
C0003405 (UMLS CUI [2,2])
C0178602 (UMLS CUI [2,3])
C0205272 (UMLS CUI [2,4])
C0439165 (UMLS CUI [1,2])
C3639721 (UMLS CUI [1,3])
C0231290 (UMLS CUI [2,1])
C0003405 (UMLS CUI [2,2])
C0178602 (UMLS CUI [2,3])
C0205272 (UMLS CUI [2,4])
Mini-mental state examination
Item
mmse score of 25 or higher
boolean
C0451306 (UMLS CUI [1])
Exclusion Criteria Main
Item
main exclusion criteria:
boolean
C0680251 (UMLS CUI [1,1])
C1542147 (UMLS CUI [1,2])
C1542147 (UMLS CUI [1,2])
Atypical Parkinsonism | Secondary Parkinson Disease
Item
atypical or secondary parkinsonism.
boolean
C4302185 (UMLS CUI [1])
C0030569 (UMLS CUI [2])
C0030569 (UMLS CUI [2])
Antipsychotic Agents
Item
prior use of neuroleptic agents.
boolean
C0040615 (UMLS CUI [1])
Intracranial procedure Parkinson Disease
Item
history of intracranial procedures for pd.
boolean
C1299207 (UMLS CUI [1,1])
C0030567 (UMLS CUI [1,2])
C0030567 (UMLS CUI [1,2])
Psychotic Disorders
Item
active psychosis.
boolean
C0033975 (UMLS CUI [1])
Substance Use Disorders
Item
history of drug or alcohol abuse in past 12 months.
boolean
C0038586 (UMLS CUI [1])
Cardiac conduction abnormality
Item
cardiac conduction system abnormality.
boolean
C1842820 (UMLS CUI [1])
Predisposition Causing Nausea | Predisposition Causing Vomiting | Predisposition Causing Usage Antiemetics
Item
predisposing medical condition that causes nausea or vomiting or routine use of an anti-emetic.
boolean
C0220898 (UMLS CUI [1,1])
C0678227 (UMLS CUI [1,2])
C0027497 (UMLS CUI [1,3])
C0220898 (UMLS CUI [2,1])
C0678227 (UMLS CUI [2,2])
C0042963 (UMLS CUI [2,3])
C0220898 (UMLS CUI [3,1])
C0678227 (UMLS CUI [3,2])
C0457083 (UMLS CUI [3,3])
C0003297 (UMLS CUI [3,4])
C0678227 (UMLS CUI [1,2])
C0027497 (UMLS CUI [1,3])
C0220898 (UMLS CUI [2,1])
C0678227 (UMLS CUI [2,2])
C0042963 (UMLS CUI [2,3])
C0220898 (UMLS CUI [3,1])
C0678227 (UMLS CUI [3,2])
C0457083 (UMLS CUI [3,3])
C0003297 (UMLS CUI [3,4])